Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 3

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
Hypoxic-ischemic encephalopathy (HIE) results in permanent damage of the central nervous system that may result in neonatal death or developmental disorders. 20% – 30% of infants with HIE die in the neonatal period, and 33% – 50% of survivors demonstrate permanent neurodevelopmental abnormalities, such as cerebral palsy and mental retardation. It was shown recently that group II metabotropic glutamate receptor (mGluR2/3) activation before or after ischemic insult results in neuroprotection, but the exact mechanism of this effect is not clear. AIM(S): The aim of present study was to investigate whether mGluR2/3 activation after hypoxia‑ischemia reduces brain damage and if the reduction of the expression of pro-apoptotic factors is one of the mechanisms involved. METHOD(S): We used an animal model of hypoxia‑ischemia (H‑I) on 7‑day old rat pups. Animals were anesthetized and the left common carotid artery was isolated, double-ligated and then cut between the ligatures. After completion of the surgical procedure, the pups were subjected to hypoxia (7.4% oxygen in nitrogen for 75 min at 35˚C). Control pups were sham‑operated (anaesthetized and left c.c.a. dissected, but not ligated). Animals were injected intraperitoneally with specific mGluR2 (LY 379268) and mGluR3 (NAAG) agonists 1 h or 6 h after H‑I (5 mg/kg of body weight). The weight deficit of the ischemic brain hemisphere was measured and expression of Bax, Bcl‑2, and HTR/OMI was examined. Damage in the hippocampal CA1 region was examined by cresyl violet (CV) staining. RESULTS: Our results show that application of mGluR2/3 agonists after H‑I results in neuroprotection. Both applied agonists decreased brain tissue weight loss in ischemic hemisphere at both times of application (from 40% in H‑I to 15% – 20% in treated). Histological examination of the brain tissue showed that both mGluR2/3 agonists applied 1h or 6 h after H‑I decreased the damage of neuronal cells and the disorganization of CA1 region of hippocampus. Both agonist mGluR2/3 applied 1h or 6 h after H‑I were associated with decreased expression of BAX and HTR/OMI and increased expression of Bcl-2 in the ischemic brain hemisphere as compared to H‑I. CONCLUSIONS: The results show that activation of mGluR2 or mGluR3 in a short time after H-I insult triggered neuroprotective mechanisms and reduced apoptotic processes initiated by H‑I in the developing brain. FINANCIAL SUPPORT: This work was performed under the 2016/23/N/NZ7/01942 project.
BACKGROUND AND AIMS: Perinatal asphyxia is characterized by clinical and laboratory evidence of acute brain injury due to asphyxia. It was shown that mGluR2/3 activation before or after ischemic insult results in neuroprotection but the exact mechanism of this effect is not clear. The aim of present study was to investigate whether mGluR2/3 activation after hypoxia-ischemia (HI) reduces brain damage and if the activation of antioxidant enzymes and decrease of oxidative stress. METHODS: We used an animal model of HI on 7-day old rat pups. Animals were anesthetized and the left common carotid artery was isolated and double-ligated and then cut between the ligatures. After completion of the surgical procedure the pups were subjected to hypoxia (7.4% oxygen in nitrogen for 75 min at 35°C). Animals were injected intraperitoneal with specific mGluR2 (LY379268) and mGluR3 (NAAG) agonists 24 h or 1 h after HI. First weight deficit of HI brain hemisphere were measured and examined the expression of Bax. Next in our investigation we were used TUNEL assay and TTC1% staining. RESULTS: Our results show a neuroprotective effect  of mGluR2/3 agonists.Both agonists applied decreased brain tissue weight loss in ischemic hemisphere independently on the time of application (from 40% in HI to 15–20% in treated). In our study we show the relative changes in the expression of Bax protein in ipsilateral and contralateral hemisphere. Our results show that both mGluR2/3 antagonists applied 24 h and 1 h after HI reduced number of TUNELpositive cells in ipsilateral hemispheres. We observed more number of TUNEL- positive cells in HI. Both mGluR2/3 agonists decreased area of ipsilateral hemisphere infraction. CONCLUSIONS: This study is the demonstration of the neuroprotective effect of mGluR2/3 agonist on neonatal HI brain injury. These data suggest the possibility that preconditioning reduces irreversible ischemic injury in part by decreasing apoptosis.
INTRODUCTION: Birth asphyxia results in serious damage of central nervous system or neonatal death. It was shown recently that group II metabotropic glutamate receptors (mGluR2/3) activation results in neuroprotection but the exact mechanism of this effect is not clear. AIM(S): The aim of present study was to investigate whether neuroprotective effect of mGluR2/3 activation is connected with inhibition of apoptosis and activation of pro-survival neurotrophic factors. METHOD(S): We used hypoxia-ischemia (HI) on 7-day old rat pups as animal model of birth asphyxia. Animals were anesthetized and the left common carotid artery was isolated, double-ligated and cut between the ligatures. After 60 min of recovery the pups were subjected to hypoxia (7.4% oxygen in nitrogen for 75 min.). Control pups were sham-operated. Animals were injected i.p. with specific mGluR2 (LY379268) and mGluR3 (NAAG) agonists 1h or 6h after HI (5 mg/kg of b.w.). The weight deficit ofthe ischemic brain hemisphere was measured and the expression of Bax, Bcl-2, HTR/OMI was examined. The damage in the hippocampal CA1 region was examined by Cresyl violet staining. Differences in the expression of neurotrophic factors (BDNF, GDNF, TGF –beta) were measured using ELISA. RESULTS: Our results show that application of mGluR2/3 agonists after HI reduce brain damage. Both applied agonists decreased weight loss in ischemic hemisphere independently on the time of application by 50% and reduced the damage of CA1 region of hippocampus. Both mGluR2/3 agonists inhibited HI induced increase in expression of Bax and HTR/OMI and restored, decreased after HI, expression of Bcl-2. LY379268 and NAAG applied 1h or 6h after HI increased TGF beta expression and expression of BDNF and GDNF in the ischemic brain hemisphere. CONCLUSIONS: Neuroprotective effect of mGluR2/3 activation after HI insult is connected with reduction of apoptotic processes and activation of pro-survival neurotrophic factors. FINANCIAL SUPPORT: This work was made under MMRC-KNOW 2013–2017 project.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.